Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Clinical trial data shows retatrutide has somewhat higher rates of GI side effects (nausea, diarrhea, vomiting) compared to tirzepatide, likely due to the additional glucagon receptor activation
Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors
Made in: Cyprus Pack size: 30 ml Servings per container: 30 Serving size: 1 Primary Ingredients Peptide Complex Other ingredients Purified Water, Preservatives: Sodium Benzoate, Potassium Sorbate
Carnitine Health Professional Fact Sheet (nih.gov), accessed September 2023
Across the SURPASS program, weight loss associated with tirzepatide explained the majority of treatment effect on SBP
However, your healthcare provider may schedule more frequent monitoring during the transition period
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
